dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Moy, Beverly |
dc.contributor.author | Antunes de Melo Oliveira, Ana Mafalda |
dc.contributor.author | Gradishar, William |
dc.contributor.author | Kim, Sung‑Bae |
dc.contributor.author | Brufsky, Adam |
dc.contributor.author | Saura Manich, Cristina |
dc.date.accessioned | 2022-06-15T10:54:34Z |
dc.date.available | 2022-06-15T10:54:34Z |
dc.date.issued | 2021-07 |
dc.identifier.citation | Moy B, Oliveira M, Saura C, Gradishar W, Kim SB, Brufsky A, et al. Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens. Breast Cancer Res Treat. 2021 Jul;188:449–458. |
dc.identifier.issn | 1460-2156 |
dc.identifier.uri | https://hdl.handle.net/11351/7682 |
dc.description | Calidad de vida relacionada con la salud; Cáncer de mama metastásico; Neratinib |
dc.language.iso | eng |
dc.publisher | Oxford University Press |
dc.relation.ispartofseries | Breast Cancer Research and Treatment;188 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Mama - Càncer - Tractament |
dc.subject | Medicaments antineoplàstics - Ús terapèutic |
dc.subject | Qualitat de vida - Avaluació |
dc.subject.mesh | Breast Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Antineoplastic Combined Chemotherapy Protocols |
dc.title | Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1007/s10549-021-06217-4 |
dc.subject.decs | neoplasias de la mama |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | protocolos de quimioterapia antineoplásica combinada |
dc.relation.publishversion | https://doi.org/10.1007/s10549-021-06217-4 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Moy B] Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA 02114, USA. [Oliveira M, Saura C] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Gradishar W] Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA. [Kim SB] Asan Medical Center, University of Ulsan College of Medicine, Seoul, Kore. [Brufsky A] Magee-Womens Hospital of UPMC, Pittsburgh, PA, USA |
dc.identifier.pmid | 33909203 |
dc.identifier.wos | 000710927500019 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |